137 related articles for article (PubMed ID: 17510306)
1. Microtransponder-based multiplex assay for genotyping cystic fibrosis.
Lin X; Flint JA; Azaro M; Coradetti T; Kopacka WM; Streck DL; Wang Z; Dermody J; Mandecki W
Clin Chem; 2007 Jul; 53(7):1372-6. PubMed ID: 17510306
[TBL] [Abstract][Full Text] [Related]
2. The Spectrum of CFTR Variants in Nonwhite Cystic Fibrosis Patients: Implications for Molecular Diagnostic Testing.
Schrijver I; Pique L; Graham S; Pearl M; Cherry A; Kharrazi M
J Mol Diagn; 2016 Jan; 18(1):39-50. PubMed ID: 26708955
[TBL] [Abstract][Full Text] [Related]
3. Identification of novel and rare mutations in California Hispanic and African American cystic fibrosis patients.
Alper OM; Wong LJ; Young S; Pearl M; Graham S; Sherwin J; Nussbaum E; Nielson D; Platzker A; Davies Z; Lieberthal A; Chin T; Shay G; Hardy K; Kharrazi M
Hum Mutat; 2004 Oct; 24(4):353. PubMed ID: 15365999
[TBL] [Abstract][Full Text] [Related]
4. Microsphere bead arrays and sequence validation of 5/7/9T genotypes for multiplex screening of cystic fibrosis polymorphisms.
Hadd AG; Laosinchai-Wolf W; Novak CR; Badgett MR; Isgur LA; Goldrick M; Walkerpeach CR
J Mol Diagn; 2004 Nov; 6(4):348-55. PubMed ID: 15507674
[TBL] [Abstract][Full Text] [Related]
5. CFTR mutation distribution among U.S. Hispanic and African American individuals: evaluation in cystic fibrosis patient and carrier screening populations.
Sugarman EA; Rohlfs EM; Silverman LM; Allitto BA
Genet Med; 2004; 6(5):392-9. PubMed ID: 15371903
[TBL] [Abstract][Full Text] [Related]
6. Cystic fibrosis carrier testing in an ethnically diverse US population.
Rohlfs EM; Zhou Z; Heim RA; Nagan N; Rosenblum LS; Flynn K; Scholl T; Akmaev VR; Sirko-Osadsa DA; Allitto BA; Sugarman EA
Clin Chem; 2011 Jun; 57(6):841-8. PubMed ID: 21474639
[TBL] [Abstract][Full Text] [Related]
7. A simple, fast and inexpensive method for mutation scanning of CFTR gene.
Figueredo Lago JE; Armas Cayarga A; González González YJ; Collazo Mesa T
BMC Med Genet; 2017 May; 18(1):58. PubMed ID: 28545452
[TBL] [Abstract][Full Text] [Related]
8. Cystic fibrosis newborn screening programs: implications of the CFTR variant spectrum in nonwhite patients.
Pique L; Graham S; Pearl M; Kharrazi M; Schrijver I
Genet Med; 2017 Jan; 19(1):36-44. PubMed ID: 27148940
[TBL] [Abstract][Full Text] [Related]
9. Clinical Sensitivity of Cystic Fibrosis Mutation Panels in a Diverse Population.
Hughes EE; Stevens CF; Saavedra-Matiz CA; Tavakoli NP; Krein LM; Parker A; Zhang Z; Maloney B; Vogel B; DeCelie-Germana J; Kier C; Anbar RD; Berdella MN; Comber PG; Dozor AJ; Goetz DM; Guida L; Kattan M; Ting A; Voter KZ; ; van Roey P; Caggana M; Kay DM
Hum Mutat; 2016 Feb; 37(2):201-8. PubMed ID: 26538069
[TBL] [Abstract][Full Text] [Related]
10. Cystic fibrosis carrier screening in a North American population.
Zvereff VV; Faruki H; Edwards M; Friedman KJ
Genet Med; 2014 Jul; 16(7):539-46. PubMed ID: 24357848
[TBL] [Abstract][Full Text] [Related]
11. Non-radioactive detection of the most common mutations in the cystic fibrosis transmembrane conductance regulator gene by multiplex allele-specific polymerase chain reaction.
Fortina P; Conant R; Monokian G; Dotti G; Parrella T; Hitchcock W; Kant J; Scanlin T; Rappaport E; Schwartz E
Hum Genet; 1992 Dec; 90(4):375-8. PubMed ID: 1282898
[TBL] [Abstract][Full Text] [Related]
12. Heterogeneous spectrum of CFTR gene mutations in Korean patients with cystic fibrosis.
Jung H; Ki CS; Koh WJ; Ahn KM; Lee SI; Kim JH; Ko JS; Seo JK; Cha SI; Lee ES; Kim JW
Korean J Lab Med; 2011 Jul; 31(3):219-24. PubMed ID: 21779199
[TBL] [Abstract][Full Text] [Related]
13. Symmetric snapback primers for scanning and genotyping of the cystic fibrosis transmembrane conductance regulator gene.
Zhou L; Palais RA; Ye F; Chen J; Montgomery JL; Wittwer CT
Clin Chem; 2013 Jul; 59(7):1052-61. PubMed ID: 23503723
[TBL] [Abstract][Full Text] [Related]
14. Direct visualization of cystic fibrosis transmembrane regulator mutations in the clinical laboratory setting.
Strom CM; Clark DD; Hantash FM; Rea L; Anderson B; Maul D; Huang D; Traul D; Chen Tubman C; Garcia R; Hess PP; Wang H; Crossley B; Woodruff E; Chen R; Killeen M; Sun W; Beer J; Avens H; Polisky B; Jenison RD
Clin Chem; 2004 May; 50(5):836-45. PubMed ID: 15010427
[TBL] [Abstract][Full Text] [Related]
15. Detection of F508del mutation in cystic fibrosis transmembrane conductance regulator gene mutation among Malays.
Zilfalil BA; Sarina S; Liza-Sharmini AT; Oldfield NJ; Stenhouse SA
Singapore Med J; 2006 Feb; 47(2):129-33. PubMed ID: 16435054
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the CFTR gene in Iranian cystic fibrosis patients: identification of eight novel mutations.
Alibakhshi R; Kianishirazi R; Cassiman JJ; Zamani M; Cuppens H
J Cyst Fibros; 2008 Mar; 7(2):102-9. PubMed ID: 17662673
[TBL] [Abstract][Full Text] [Related]
17. Genotyping microarray for the detection of more than 200 CFTR mutations in ethnically diverse populations.
Schrijver I; Oitmaa E; Metspalu A; Gardner P
J Mol Diagn; 2005 Aug; 7(3):375-87. PubMed ID: 16049310
[TBL] [Abstract][Full Text] [Related]
18. Fluorescence-based oligonucleotide ligation assay for analysis of cystic fibrosis transmembrane conductance regulator gene mutations.
Eggerding FA; Iovannisci DM; Brinson E; Grossman P; Winn-Deen ES
Hum Mutat; 1995; 5(2):153-65. PubMed ID: 7538376
[TBL] [Abstract][Full Text] [Related]
19. Application of multiplex ARMS and SSCP/HD analysis in molecular diagnosis of cystic fibrosis in Indian patients.
Ashavaid TF; Kondkar AA; Dherai AJ; Raghavan R; Udani SV; Udwadia ZF; Desai D
Mol Diagn; 2005; 9(2):59-66. PubMed ID: 16137181
[TBL] [Abstract][Full Text] [Related]
20. Cystic Fibrosis Gene Mutation Frequency Among a Group of Suspected Children in King Hussein Medical Center.
Al-Abadi B; Al-Hiary M; Khasawneh R; Al-Momani A; Bani-Salameh A; Al-Saeidat S; Al-Khlaifat A; Aboalsondos O
Med Arch; 2019 Apr; 73(2):118-120. PubMed ID: 31391700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
